Literature DB >> 27821431

Developmental Wiring of Specific Neurons Is Regulated by RET-1/Nogo-A in Caenorhabditis elegans.

Nanna Torpe1, Steffen Nørgaard1,2, Anette M Høye1, Roger Pocock3,2.   

Abstract

Nogo-A is a membrane-bound protein that functions to inhibit neuronal migration, adhesion, and neurite outgrowth during development. In the mature nervous system, Nogo-A stabilizes neuronal wiring to inhibit neuronal plasticity and regeneration after injury. Here, we show that RET-1, the sole Nogo-A homolog in Caenorhabditis elegans, is required to control developmental wiring of a specific subset of neurons. In ret-1 deletion mutant animals, specific ventral nerve cord axons are misguided where they fail to respect the ventral midline boundary. We found that ret-1 is expressed in multiple neurons during development, and, through mosaic analysis, showed that ret-1 controls axon guidance in a cell-autonomous manner. Finally, as in mammals, ret-1 regulates ephrin expression, and dysregulation of the ephrin ligand VAB-2 is partially responsible for the ret-1 mutant axonal defects. Together, our data present a previously unidentified function for RET-1 in the nervous system of C. elegans.
Copyright © 2017 by the Genetics Society of America.

Entities:  

Keywords:  C. elegans; Nogo-A; axon guidance; ephrin

Mesh:

Substances:

Year:  2016        PMID: 27821431      PMCID: PMC5223509          DOI: 10.1534/genetics.115.185322

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


THE establishment and maintenance of neuronal circuits is driven by the ability of neurons to receive and process cues from other neurons, glia, and the extracellular matrix (ECM) (Tessier-Lavigne and Goodman 1996; Yu and Bargmann 2001). Axon guidance is particularly reliant on the correct organization of molecular cues, since axons often extend projections over long distances with many intermediate targets (Garel and Rubenstein 2004). Axon guidance cues generally function as either repellents or attractants depending on the complement of receptors that are presented on axonal growth cones. There is also a complex milieu of axon guidance cues that extending growth cones encounter during development. This means that precise spatial and temporal regulation of these cues is required to ensure faithful development of the nervous system. Recently, dysregulation of axon guidance proteins has also been implicated in several neurological disorders, such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD) (Nugent ; Cissé and Checler 2015; Van Battum ). Reticulons (RTNs) are membrane-bound proteins located on the cell surface and the endoplasmic reticulum (ER), where they are involved in bending and shaping of the ER membrane and in trafficking from the ER to the Golgi apparatus (Yang and Strittmatter 2007; O’Sullivan ). RTNs are characterized by a carboxy terminal reticulon homology domain (RHD), which comprises two long hydrophobic regions flanking a hydrophilic loop. Four genes encode RTN proteins in mammals: RTN1, RTN2, RTN3 and RTN4/Nogo (Oertle ; Di Sano ). Dysregulation of the neurite outgrowth inhibitory molecule RTN4/Nogo is implicated in ALS and multiple sclerosis (MS) (Bros-Facer ; Schmandke ). ALS patients, and mouse models of ALS (SOD-1G86R), show an upregulation of Nogo in skeletal muscle, and, as such, Nogo is used as a prognostic biomarker, successfully identifying patients progressing from lower motor neuron syndrome to ALS (Dupuis ; Pradat ). The most widely studied RTN is Nogo-A, a multifunctional protein implicated in numerous developmental processes such as cell migration, central nervous system (CNS) plasticity, and neuronal regeneration. The role of Nogo-A in spinal cord injury has also been extensively studied, initially due to the identification of Nogo-A as one of the major neurite growth inhibitory components of myelin in the CNS (Caroni and Schwab 1988a,b). Inhibitors of Nogo-A and the Nogo-A receptor, NgR1, were subsequently shown to enhance regenerative sprouting and growth of damaged fibers after spinal cord injury (Freund ). Consequently, several clinical studies are currently being performed, by Novartis (ATI 355) and GlaxoSmithKline (Ozanezumab), using such inhibitors to treat spinal cord injury, ALS, and multiple sclerosis. Despite the implication of Nogo-A in neurogenerative disease, only a few reports have studied the role of Nogo-A in neuronal development (Wang , 2010; Pinzón-Olejua ). In this study, we have used the invertebrate model system Caenorhabditis elegans to dissect Nogo-A functions in neuronal development. In C. elegans, there is a single Nogo-A homolog called RET-1. Previous studies have shown that knockdown of through RNA-mediated interference (RNAi) interferes with ER formation during mitosis, and it has further been shown to interact with a regulator of endocytic recycling, RME-1 (Iwahashi ; Audhya ). Here, we show that is highly expressed in the left and right ventral nerve cord (VNC), the embryonic motor neurons (eMNs), and the hermaphrodite specific neurons (HSN) in C. elegans. We subsequently performed single neuron resolution analysis of developed axons in loss-of-function mutant animals. We found that is required for the correct extension of the PVP and PVQ interneurons and the HSN motor neurons—these axons fail to respect the ventral midline, and inappropriately cross over to the contralateral side in mutant animals. Ephrin signaling is known to play a prominent role in VNC axon guidance. Interestingly, we found that mutant HSN guidance defects are dependent on expression of the ephrin ligand VAB-2. The suppression of the mutant HSN axon guidance defects by loss of VAB-2 is dependent on the Eph receptor VAB-1. This suggests that inappropriate spatial or temporal expression of VAB-2 causes defective ephrin signaling leading to axon guidance defects in mutant animals. Therefore, our findings indicate a function for this gene family that is conserved, and lays the foundation for further studies on the function of RET-1 in the genetically tractable nematode system.

Materials and Methods

Caenorhabditis elegans maintenance

All C. elegans strains were cultured at 20° as previously described (Brenner 1974). All strains generated and used in this study are detailed in Supplemental Material, Table S1.

Mosaic analysis

For mosaic analysis, transgenic animals were generated by injecting rgef-1::ret-1 isoform g.2 cDNA, tph-1::mCherry and myo-2::mCherry into ; animals. A transgenic line was selected that exhibited complete HSN axon guidance rescue. Transgenic animals from this line were then scored for phenotypic rescue of the HSN axon guidance defects in the presence or absence of the rescuing array in the HSN neurons by detection of mCherry fluorescence.

DNA constructs and transgenic lines

Rescue constructs were injected into the mutant background at 5–15 ng/µl with myo-2::mCherry (5 ng/µl) as injection marker. Expression constructs were injected into the N2 background at 50 ng/µl with myo-2::mCherry (5 ng/µl) as injection marker. The 9 kb rescuing PCR fragment was injected into at 1 ng/µl with myo-2::mCherry (5 ng/µl) as injection marker.

Fluorescence microscopy

Neuroanatomy was scored in L4 and young adult hermaphrodites by mounting on 5% agarose on glass slides. Images were taken using an automated fluorescence microscope (Zeiss, AXIO Imager M2) and ZEN software (version 3.1).

qRT-PCR assays

RNA was isolated from a mixed-stage worm population using standard Trizol-based methods (Chomczynski and Sacchi 1987). Total cDNA was obtained using TaqMan Reverse Transcription Reagents (Invitrogen, Cat. No: N8080234). qRT-PCR reactions were performed in triplicate on a LightCycler 480 System (Roche) using the Maxima SYBR/ROX qRT-PCR Master Mix (Fermentas, Cat. No: K0221). Error bars represent the SEM of at least three independent sets of samples. qRT-PCR assays were normalized with two reference genes ( and ).

Statistical analysis

Statistical analysis was performed in GraphPad Prism 6 using one-way ANOVA for comparison followed by Dunnett’s Multiple Comparison Test or Tukey’s Multiple Comparison Test, where applicable. Values are expressed as mean ± SD. Differences with a P value <0.05 were considered significant.

Data availability

The authors state that all data necessary for confirming the conclusions presented in the article are represented fully within the article. Strains are available upon request.

Results

ret-1 is expressed in the nervous system

Nogo-A is reported to function in neurodevelopmental processes, neuroplasticity, and neuronal regeneration, and has been implicated in a range of neurodegenerative diseases (Caroni and Schwab 1988a; Buffo ). Recent studies investigated the role of axon guidance proteins in neurodegeneration, and found several guidance cues implicated in the development of these disorders (Engle 2010; Nugent ; Van Battum ). We therefore hypothesized that Nogo-A could play a role in axon guidance, and investigated this by analyzing RET-1, the C. elegans Nogo-A homolog. The locus in C. elegans contains eight isoforms, predicted to encode proteins that range from 204 to 3303 amino acids (Figure 1). All protein isoforms harbor an RHD at their carboxy terminus; however, the ModENCODE project showed that the shorter isoforms are predominantly expressed in C. elegans (Gerstein ). We therefore focused our expression and functional analysis on ret-1 isoform g.2 (Figure 1). First, we examined the expression pattern using a transgenic fluorescent reporter strain in which GFP is driven under the control of a promoter region upstream of isoform g.2 (designated as prom) (Figure 1). Fluorescence in the transcriptional ret-1::GFP reporter strain was diffuse during early embryogenesis, then robustly detected in several head neurons in the twofold stage of the embryo (Figure 1). Postembryonically, is extensively expressed in the nervous system, with prominent expression in the nerve ring and VNC motor neurons, and other VNC neurons, including the HSNs.
Figure 1

The C. elegans Nogo-A/RTN4 homolog RET-1 is expressed in the nervous system. (A) Alignment of the C-terminus of C. elegans RET-1 with the Nogo-A/RTN4 homologs of mouse, rat and human. The RHD is highlighted in gray. Alignment was generated using ClustalW. (B) The ret-1 locus comprises eight isoforms encoding predicted proteins of 204–3303 amino acids. All isoforms harbor an RHD in their C-termini. The deletion alleles (marked by red bars) used in this study (gk242 and tm390) both affect the RHD and produce frameshifts. The DNA sequence that encodes the RHD is marked by a black bar at the C terminus. We used ret-1 isoform g.2 as a model to study the ret-1 expression pattern and function. The ret-1 isoform g.2 5000 bp promoter used to report expression (ret-1::gfp - now written as ret-1::gfp) is shown below the locus. (C–G) Expression of the transcriptional ret-1::gfp reporter during embryonic and young adult stages. (C–F) At the bean stage, ret-1::gfp is diffusely expressed (D); however, robust expression is observed in the twofold stage of the embryo in two head neurons (F). (C, E) DIC images of the fluorescent images shown in (D) and (F). Postembryonically, ret-1::gfp is highly expressed in embryonic motor neurons [eMNs, white arrowheads in (G) and (H)] and hermaphrodite-specific neurons [HSNs, red arrowheads in (G)], the head [red arrowhead in (H) points to the nerve ring], and the tail. All images are lateral views, except the ventral view in (G). Anterior to the left. Bars, 10 μm.

The C. elegans Nogo-A/RTN4 homolog RET-1 is expressed in the nervous system. (A) Alignment of the C-terminus of C. elegans RET-1 with the Nogo-A/RTN4 homologs of mouse, rat and human. The RHD is highlighted in gray. Alignment was generated using ClustalW. (B) The ret-1 locus comprises eight isoforms encoding predicted proteins of 204–3303 amino acids. All isoforms harbor an RHD in their C-termini. The deletion alleles (marked by red bars) used in this study (gk242 and tm390) both affect the RHD and produce frameshifts. The DNA sequence that encodes the RHD is marked by a black bar at the C terminus. We used ret-1 isoform g.2 as a model to study the ret-1 expression pattern and function. The ret-1 isoform g.2 5000 bp promoter used to report expression (ret-1::gfp - now written as ret-1::gfp) is shown below the locus. (C–G) Expression of the transcriptional ret-1::gfp reporter during embryonic and young adult stages. (C–F) At the bean stage, ret-1::gfp is diffusely expressed (D); however, robust expression is observed in the twofold stage of the embryo in two head neurons (F). (C, E) DIC images of the fluorescent images shown in (D) and (F). Postembryonically, ret-1::gfp is highly expressed in embryonic motor neurons [eMNs, white arrowheads in (G) and (H)] and hermaphrodite-specific neurons [HSNs, red arrowheads in (G)], the head [red arrowhead in (H) points to the nerve ring], and the tail. All images are lateral views, except the ventral view in (G). Anterior to the left. Bars, 10 μm.

ret-1 mutants display VNC axon guidance defects

Since is expressed in the nervous system, and prominently in neurons that navigate the VNC, we investigated if plays a role in axon guidance at the VNC. To analyze the function of , we obtained two independently isolated deletion alleles of the locus, and , from C. elegans knockout consortia. Both deletion alleles are predicted to cause a frameshift mutation resulting in a premature stop codon affecting all isoforms (Figure 1). Thus, the resultant mutant RET-1 proteins are not predicted to have functional RHDs. We initially focused on the development of the HSN neurons, which have been extensively studied, and are known to be regulated by a range of highly conserved axon guidance molecules (Desai ; Wightman ; Zallen ; Boulin ; Pocock and Hobert 2008; Pedersen ; Torpe and Pocock 2014). The bilateral HSN neurons are born during embryogenesis, and subsequently migrate toward the presumptive midbody region of the embryo (Sulston and Horvitz 1977; Desai ). During larval development, the left and right HSNs (HSNL/R) extend their axons toward the vulval precursor cells at the ventral midline of the worm. Next, they extend anteriorly in two separate VNC axon bundles until they reach the head, where they connect with other neurons at the nerve ring (Adler ). We found that loss of , using the and deletion alleles, causes 40–50% penetrant defects in HSN axon guidance, where axons inappropriately crossover to the contralateral side (Figure 2, A and B, and Table 1). In contrast, HSN cell migration occurs normally in mutant animals (Table 1). To confirm that the HSN axon guidance defects are caused by loss of , we transgenically resupplied genomic DNA (isoforms a, b, e, and g.2), driven by its own promoter, in mutant animals (Figure 2C). We found that transgenic expression of genomic DNA fully rescues HSN axon guidance defects in the mutant (Figure 2C). To investigate if can act as an instructive signaling cue, we overexpressed genomic DNA in wild-type animals. Introducing extra copies of did not cause axon guidance defects in wild-type worms, suggesting that cannot act as an instructive molecule for HSN axon guidance (Figure 2C). We confirmed that acts in the nervous system to control HSN guidance by driving the cDNA encoding ret-1 isoform g.2 under the control of the promoter in animals (Figure 2D). We next performed mosaic analysis to confirm whether is required cell-autonomously in the HSNs to control axon guidance. Axon guidance defects were fully rescued when the -rescuing array was present in the HSNs (5/69 animals, 7%, were defective), whereas loss of the array from the HSNs abrogated rescue (6/14 animals, 43%, were defective). These data indicate that ret-1 isoform g.2 acts cell autonomously to direct axon guidance of the HSNs. In addition, expression of the other isoforms is not required for the control of HSN axon guidance, or any isoform that contains the RHD can function in this regard.
Figure 2

ret-1 acts in neurons to control HSN axon guidance. (A) Schematic of HSN anatomy in adults (top). HSNs migrate during embryogenesis to the midbody. During larval stages, the HSN left and right axons extend into the vulva, and subsequently into the VNC, where they terminate at the nerve ring in the head. HSN anatomy of wild-type (center) and ret-1(gk242) (bottom) animals. HSN cell bodies in ret-1(gk242) animals migrate to their correct position just posterior to the vulva. However, axonal defects were observed where one axon crosses over to the contralateral side (red arrowhead). The vulva is marked with a red asterisk. Ventral view, anterior to the left. HSN development was studied using a tph-1::gfp transgene (zdIs13). Bar, 20 μm. (B) Quantification of HSN axonal crossover defects in two independent ret-1 deletion mutants: gk242 and tm390. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001. (C) Transgenic expression of ret-1 genomic DNA rescues HSN defects of ret-1(gk242) mutant animals, whereas transgenic overexpression of ret-1 genomic DNA in wild type animals does not induce defects. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.001. n.s., not significant; # refers to independent transgenic lines. (D) Transgenic expression of ret-1 isoform g.2 cDNA in the nervous system, using the panneuronal rgef-1 promoter, rescues HSN defects of ret-1(gk242) mutant animals. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001; # refers to independent transgenic lines.

Table 1

Quantification of neuroanatomical scoring in wild type and ret-1(gk242) mutant animals

Neurons Examined (Marker Used)% Defective Animals
Wild Typeret-1(gk242)P Value
Interneurons
 PVQ interneurons (hdIs26)a616****
 PVP interneurons (hdIs26)b617****
Motor Neurons
 HSN motor neurons (zdIs13)c
  Axon guidance841****
  Cell migration56n.s.
L/R choiced
 D motor neuron (oxIs12)1137****
 DA/DB MN (evIs82b)915n.s.
Defasciculatione
 Ventral nerve cord
  D motor neuron (oxIs12)033****
  DA/DB MN (evIs82b)00n.s.
Mechanosensory Neurons (zdIs4)f
 PLM611n.s.
 ALM23n.s.
 PVM52n.s.
 AVM011****

We used a panel of gfp reporter strains that highlight specific neurons in wild type and ret-1(gk242) mutant animals. The wiring of the wild type nervous system was used as control when scoring the axon guidance defects in ret-1(gk242) mutants. Animals were scored 1-day post-L4 on ≥2 consecutive days, n ≥ 50 animals.

PVQ interneurons were scored defective when PVQ right or PVQ left axons crossed over to the contralateral side.

PVP interneurons were scored defective when PVP right or PVP left axons crossed over to the contralateral side.

HSN motor neurons were scored defective for axon crossover defects and cell migration. Axon guidance was scored as for the interneurons above. Wild type levels of HSN cell migration defects were observed in ret-1(gk242) mutant animals.

Left/right asymmetry was scored as defective when the commissures extended to the inappropriate side.

Fasciculation of the dorsal nerve cord and VNC were scored as defective when ≥2 processes were separated from the fascicle.

Touch cells: PLMs and ALMs were scored defective when synapses from the PLMs or ALMs failed to extend to the VNC. The AVM and PVM neurons were scored defective when the cell body position was anteriorly displaced. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001. n.s., not significant.

ret-1 acts in neurons to control HSN axon guidance. (A) Schematic of HSN anatomy in adults (top). HSNs migrate during embryogenesis to the midbody. During larval stages, the HSN left and right axons extend into the vulva, and subsequently into the VNC, where they terminate at the nerve ring in the head. HSN anatomy of wild-type (center) and ret-1(gk242) (bottom) animals. HSN cell bodies in ret-1(gk242) animals migrate to their correct position just posterior to the vulva. However, axonal defects were observed where one axon crosses over to the contralateral side (red arrowhead). The vulva is marked with a red asterisk. Ventral view, anterior to the left. HSN development was studied using a tph-1::gfp transgene (zdIs13). Bar, 20 μm. (B) Quantification of HSN axonal crossover defects in two independent ret-1 deletion mutants: gk242 and tm390. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001. (C) Transgenic expression of ret-1 genomic DNA rescues HSN defects of ret-1(gk242) mutant animals, whereas transgenic overexpression of ret-1 genomic DNA in wild type animals does not induce defects. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.001. n.s., not significant; # refers to independent transgenic lines. (D) Transgenic expression of ret-1 isoform g.2 cDNA in the nervous system, using the panneuronal rgef-1 promoter, rescues HSN defects of ret-1(gk242) mutant animals. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001; # refers to independent transgenic lines. We used a panel of gfp reporter strains that highlight specific neurons in wild type and ret-1(gk242) mutant animals. The wiring of the wild type nervous system was used as control when scoring the axon guidance defects in ret-1(gk242) mutants. Animals were scored 1-day post-L4 on ≥2 consecutive days, n ≥ 50 animals. PVQ interneurons were scored defective when PVQ right or PVQ left axons crossed over to the contralateral side. PVP interneurons were scored defective when PVP right or PVP left axons crossed over to the contralateral side. HSN motor neurons were scored defective for axon crossover defects and cell migration. Axon guidance was scored as for the interneurons above. Wild type levels of HSN cell migration defects were observed in ret-1(gk242) mutant animals. Left/right asymmetry was scored as defective when the commissures extended to the inappropriate side. Fasciculation of the dorsal nerve cord and VNC were scored as defective when ≥2 processes were separated from the fascicle. Touch cells: PLMs and ALMs were scored defective when synapses from the PLMs or ALMs failed to extend to the VNC. The AVM and PVM neurons were scored defective when the cell body position was anteriorly displaced. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test or Tukey’s multiple-comparison test, where applicable. n > 50, ****P < 0.0001. n.s., not significant. To further examine the role of in the nervous system, we analyzed neuronal development using a panel of neuron-specific gfp reporters. We found that axons of other VNC neurons, the PVQ and PVP interneurons, were also affected, albeit at a lower penetrance compared to the HSNs (16 and 17%, respectively) (Figure 3 and Table 1). To ask if the PVQ guidance defects are caused by deficiencies in development or maintenance of neuronal architecture, we analyzed PVQ guidance of freshly hatched L1 animals in animals. We observed similar penetrance of PVQ defects in L1 animals to young adults (18% penetrant defect, n ≥ 50). This indicates that the PVQ defects are developmental and not maintenance defects. In addition to the VNC midline defects, we discovered that loss of caused defects in the left/right asymmetry of the commissural D-type motor neurons, and in the fasciculation of the motor neuron axons in the VNC (Figure 3 and Table 1). We did not, however, observe defects in the DA and DB motor neurons (Table 1). Interestingly, cell migration was not affected in any of the cell types studied, except for minor anterior displacement of the AVM mechanosensory neuron (Table 1). Additionally, the structure of the hypodermal tissue, which acts as a substratum for multiple axon guidance events, was intact (Figure 3D). Furthermore, other types of neurons were not affected by the loss of (Table 1), indicating that the axon guidance defects are specific to certain neuronal subtypes.
Figure 3

ret-1 is required for correct guidance of a specific classes of axons at the ventral midline. (A–D) Cell type specific gfp reporters were utilized to investigate the neuroanatomy of wild-type and ret-1(gk242) mutant animals. Upper panels show a graphical view of wild-type morphology of each neuronal class (A–C) and the hypodermis (D). Representative images of wild-type and ret-1(gk242) mutant animals are shown in the center and bottom images, respectively. (A, B) The PVQ and PVP axons of ret-1(gk242) animals fail to respect the midline by crossing over to the contralateral axon fascicle. Expanded view is shown to indicate the crossover event. Neurons were visualized using the hdIs26 transgenic strain. (C) Commissural D-type motor neurons showed defective left/right asymmetry where the commissures extended to the inappropriate side. Neurons were visualized with the oxIs12 transgenic strain. Defective axonal patterning is marked with red arrowheads. (D) The general structure of the hypodermis appears normal in ret-1 mutant animals. Hypodermal cell morphology was observed using the jcIs1 transgenic strain.

ret-1 is required for correct guidance of a specific classes of axons at the ventral midline. (A–D) Cell type specific gfp reporters were utilized to investigate the neuroanatomy of wild-type and ret-1(gk242) mutant animals. Upper panels show a graphical view of wild-type morphology of each neuronal class (A–C) and the hypodermis (D). Representative images of wild-type and ret-1(gk242) mutant animals are shown in the center and bottom images, respectively. (A, B) The PVQ and PVP axons of ret-1(gk242) animals fail to respect the midline by crossing over to the contralateral axon fascicle. Expanded view is shown to indicate the crossover event. Neurons were visualized using the hdIs26 transgenic strain. (C) Commissural D-type motor neurons showed defective left/right asymmetry where the commissures extended to the inappropriate side. Neurons were visualized with the oxIs12 transgenic strain. Defective axonal patterning is marked with red arrowheads. (D) The general structure of the hypodermis appears normal in ret-1 mutant animals. Hypodermal cell morphology was observed using the jcIs1 transgenic strain.

HSN defects of ret-1 mutants are caused by dysregulated expression of the ephrin ligand VAB-2

During embryogenesis, VNC axons are separated by embryonic motor neurons that provide repulsive cues to extending VNC axons to ensure left/right fascicle separation (Boulin ). During postembryonic development, a hypodermal ridge forms and presents a physical barrier between left and right axon fascicles (White 1976; Boulin ). During both these phases of development, multiple redundant pathways are known to act in parallel to drive axon guidance. To examine the functional relationship between and these pathways, we created double mutants carrying the allele, and mutations in genes that act in axon guidance pathways (Netrin, Slit-Robo and Ephrin), and measured the penetrance of HSN axon guidance defects. As shown in Table 2, we found that genetically interacts with mutations in genes of the Netrin and Slit-Robo pathways.
Table 2

Double mutant analysis between ret-1(gk242) and known axon guidance regulators

HSN Guidance Defects (%)P Value
Wild type (zdIs13)8
ret-1(gk242)41
unc-6(ev400)97
unc-6(ev400); ret-1(gk242)95n.s.
unc-40(e1430)91
unc-40(e1430); ret-1(gk242)100n.s.
sax-3(ky123)61
sax-3(ky123); ret-1(gk242)72n.s.
slt-1(eh15)21
slt-1(eh15); ret-1(gk242)42n.s.
vab-1(dx31)44
vab-1(dx31); ret-1(gk242)49n.s.
vab-1(e2)26
vab-1(e2)36n.s.
vab-2(ju1)20
vab-2(ju1); ret-1(gk242)23<0.0001
vab-2(e96)17
vab-2(e96); ret-1(gk242)20<0.0001

Quantification of HSN axonal cross-over defects in the indicated strains. VNC defects of HSN axons in ret-1(gk242) animals are not suppressed by mutations in conserved axon guidance pathways: unc-6 and unc-40 (netrin); slt-1 and sax-3 (Slit-Robo). The penetrance of the unc-6 and unc-40 single mutants is high; therefore, only suppression of these defects in the ret-1 double mutants would be possible to detect. Such suppression of ret-1 mutant defects was observed in two alleles of the VAB-2 ephrin ligand. Data are expressed as mean ± SD, and statistical significance was assessed by ANOVA followed by Tukey’s multiple-comparison test. n > 50, n.s., not significant.

Quantification of HSN axonal cross-over defects in the indicated strains. VNC defects of HSN axons in ret-1(gk242) animals are not suppressed by mutations in conserved axon guidance pathways: unc-6 and unc-40 (netrin); slt-1 and sax-3 (Slit-Robo). The penetrance of the unc-6 and unc-40 single mutants is high; therefore, only suppression of these defects in the ret-1 double mutants would be possible to detect. Such suppression of ret-1 mutant defects was observed in two alleles of the VAB-2 ephrin ligand. Data are expressed as mean ± SD, and statistical significance was assessed by ANOVA followed by Tukey’s multiple-comparison test. n > 50, n.s., not significant. We did, however, find that two null alleles of the ephrin ligand VAB-2, but not the EFN-2 and EFN-3, suppress the HSN axon guidance defects of mutant animals (Figure 4 and data not shown). Previous work found that multiple axon guidance molecules, including ephrins, are upregulated in Nogo-A knockout adult mice, which affects neurite outgrowth (Kempf ). We therefore postulated that the HSN defects in the mutant depend on overexpression of , as removal of ameliorates the HSN axon guidance defects. We therefore analyzed the transcript level of , and found that its expression was increased in mutant animals (Figure 4A). These data suggest that dysregulation of VAB-2 expression causes, at least in part, the HSN axon guidance defects in mutant animals. We next asked whether the suppression of the HSN axon guidance defects of mutant animals by loss is dependent on the VAB-1 Eph receptor, and we found this to be the case (data not shown). Loss of VAB-1 itself is also unable to suppress the axon guidance defects of mutant animals (Figure 4B). These data suggest that and act in a similar pathway, and that overexpression of in mutant animals causes dysregulation of ephrin signaling.
Figure 4

VAB-2/ephrin expression is altered in ret-1 mutant animals, and causes HSN axon guidance defects. (A) qRT-PCR showing the expression levels of vab-2 in wild-type and ret-1(gk242) mutant animals. mRNA expression of vab-2 is increased in ret-1 mutants compared to wild type. Statistical significance was assessed by ANOVA followed by Tukey’s multiple-comparison test. ****P < 0.0001. (B) HSN axon guidance defects of ret-1 mutant animals are suppressed by mutations in the ephrin ligand VAB-2 but not by the Eph receptor VAB-1. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test. n > 50, ****P < 0.0001, n.s., not significant.

VAB-2/ephrin expression is altered in ret-1 mutant animals, and causes HSN axon guidance defects. (A) qRT-PCR showing the expression levels of vab-2 in wild-type and ret-1(gk242) mutant animals. mRNA expression of vab-2 is increased in ret-1 mutants compared to wild type. Statistical significance was assessed by ANOVA followed by Tukey’s multiple-comparison test. ****P < 0.0001. (B) HSN axon guidance defects of ret-1 mutant animals are suppressed by mutations in the ephrin ligand VAB-2 but not by the Eph receptor VAB-1. Statistical significance was assessed by ANOVA followed by Dunnett’s multiple-comparison test. n > 50, ****P < 0.0001, n.s., not significant.

Discussion

Recent studies have identified several axon guidance cues to function in neurodegenerative disease, neuronal development, and plasticity (Engle 2010; Nugent ; Van Battum ). One protein that has been intensively studied for its role in neuronal regeneration and plasticity is the neurite inhibitory protein Nogo-A; however, little is known about the role of Nogo-A in axon guidance. Here, we show that the Nogo-A homolog, , is required for the correct guidance of specific axons along the midline of C. elegans, and that the axon guidance defects in loss of function animals are caused by dysregulation of ephrin expression. We investigated the expression pattern of using a transgenic ret-1::gfp strain, which showed that is highly expressed in the nervous system, particularly in VNC motor neurons and neurons that navigate the VNC. Thus, is expressed in relevant cells that control axon guidance in the VNC. Using a panel of gfp reporters that label individual cell types, we found that is required for the correct axon guidance of a specific subset of neurons. The neuron subtypes that require RET-1 for their development (HSN, PVQ, PVP, and motor neurons) are all regulated by ephrin signaling in C. elegans (Boulin ). In mammals, it has been shown that, in the adult nervous system, loss of Nogo-A causes upregulation of developmental guidance cues, such as ephrins, at the mRNA level (Kempf ). We found that this regulatory relationship between Nogo-A and ephrin is conserved in C. elegans. Loss of causes increased mRNA expression of the ephrin . To ask whether increased ephrin expression causes the axon guidance defects observed in mutant animals, we performed double mutant analysis. First, we found that loss of the sole Eph receptor (VAB-1) in the mutant did not increase the HSN defects, which suggests that and act in the same genetic pathway, whereas, loss of the ephrin ligand VAB-2 suppresses the HSN axon guidance defects, suggesting that dysregulation of results in defective axon guidance in mutant animals. We found that the suppressive effect of loss is dependent on the presence of the VAB-1 Eph receptor. These data suggest that VAB-2 is overexpressed in mutant animals, perhaps in a temporally or spatially inappropriate manner, and interferes with VAB-1-regulated signaling. A previous study demonstrated the importance of the correct expression level, and thereby concentration, of ephrin signaling for correct function of the axon guidance signal; this study showed that a change in ephrin concentration from low to high could change the signaling cue from being perceived as a growth promoting to a growth inhibiting signaling cue (Hansen ). It is possible that a similar mechanism can cause the increase in ephrin expression we observed in the mutant to change the concentration of ephrin in certain tissues and thereby change the potency or directionality of signaling, resulting in defective HSN axon guidance. In conclusion, our study shows that is required for correct axon guidance of a specific subset of neurons that extend from, and along, the ventral midline in C. elegans. Neurons extending their axons in the left and right VNC are normally repelled by an interaction between an EphR, expressed on the extending axon, and ephrins expressed in motor neurons (Boulin ; Pocock and Hobert 2008). In deletion mutants, however, axons fail to respect the midline, and cross over to the contralateral side. We find that HSN axon guidance defects are caused by dysregulation of ephrin expression in mutant animals. Deletion of the Eph receptor VAB-1, and thereby all canonical ephrin signaling, however, does not suppress HSN defects in mutants. This suggests inappropriate signaling through ephrin (VAB-2) induction, as shown in a previous study (Pocock and Hobert 2008), causes neurodevelopmental defects in mutant animals. To conclude, we have shown that the regulatory relationship between RTN genes and axon guidance cues is conserved in C. elegans. Therefore, this work indicates that the nematode may be of further use to help decipher RTN/Nogo-A-regulated pathways, which will be of potential benefit in the battle against neurological disorders.
  39 in total

Review 1.  Dynamic regulation of axon guidance.

Authors:  T W Yu; C I Bargmann
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

Review 2.  The reticulons: guardians of the structure and function of the endoplasmic reticulum.

Authors:  Federica Di Sano; Paolo Bernardoni; Mauro Piacentini
Journal:  Exp Cell Res       Date:  2012-03-09       Impact factor: 3.905

3.  Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates.

Authors:  Patrick Freund; Eric Schmidlin; Thierry Wannier; Jocelyne Bloch; Anis Mir; Martin E Schwab; Eric M Rouiller
Journal:  Nat Med       Date:  2006-07-02       Impact factor: 53.440

4.  An epidermal microRNA regulates neuronal migration through control of the cellular glycosylation state.

Authors:  Mikael Egebjerg Pedersen; Goda Snieckute; Konstantinos Kagias; Camilla Nehammer; Hinke A B Multhaupt; John R Couchman; Roger Pocock
Journal:  Science       Date:  2013-09-20       Impact factor: 47.728

5.  Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project.

Authors:  Mark B Gerstein; Zhi John Lu; Eric L Van Nostrand; Chao Cheng; Bradley I Arshinoff; Tao Liu; Kevin Y Yip; Rebecca Robilotto; Andreas Rechtsteiner; Kohta Ikegami; Pedro Alves; Aurelien Chateigner; Marc Perry; Mitzi Morris; Raymond K Auerbach; Xin Feng; Jing Leng; Anne Vielle; Wei Niu; Kahn Rhrissorrakrai; Ashish Agarwal; Roger P Alexander; Galt Barber; Cathleen M Brdlik; Jennifer Brennan; Jeremy Jean Brouillet; Adrian Carr; Ming-Sin Cheung; Hiram Clawson; Sergio Contrino; Luke O Dannenberg; Abby F Dernburg; Arshad Desai; Lindsay Dick; Andréa C Dosé; Jiang Du; Thea Egelhofer; Sevinc Ercan; Ghia Euskirchen; Brent Ewing; Elise A Feingold; Reto Gassmann; Peter J Good; Phil Green; Francois Gullier; Michelle Gutwein; Mark S Guyer; Lukas Habegger; Ting Han; Jorja G Henikoff; Stefan R Henz; Angie Hinrichs; Heather Holster; Tony Hyman; A Leo Iniguez; Judith Janette; Morten Jensen; Masaomi Kato; W James Kent; Ellen Kephart; Vishal Khivansara; Ekta Khurana; John K Kim; Paulina Kolasinska-Zwierz; Eric C Lai; Isabel Latorre; Amber Leahey; Suzanna Lewis; Paul Lloyd; Lucas Lochovsky; Rebecca F Lowdon; Yaniv Lubling; Rachel Lyne; Michael MacCoss; Sebastian D Mackowiak; Marco Mangone; Sheldon McKay; Desirea Mecenas; Gennifer Merrihew; David M Miller; Andrew Muroyama; John I Murray; Siew-Loon Ooi; Hoang Pham; Taryn Phippen; Elicia A Preston; Nikolaus Rajewsky; Gunnar Rätsch; Heidi Rosenbaum; Joel Rozowsky; Kim Rutherford; Peter Ruzanov; Mihail Sarov; Rajkumar Sasidharan; Andrea Sboner; Paul Scheid; Eran Segal; Hyunjin Shin; Chong Shou; Frank J Slack; Cindie Slightam; Richard Smith; William C Spencer; E O Stinson; Scott Taing; Teruaki Takasaki; Dionne Vafeados; Ksenia Voronina; Guilin Wang; Nicole L Washington; Christina M Whittle; Beijing Wu; Koon-Kiu Yan; Georg Zeller; Zheng Zha; Mei Zhong; Xingliang Zhou; Julie Ahringer; Susan Strome; Kristin C Gunsalus; Gos Micklem; X Shirley Liu; Valerie Reinke; Stuart K Kim; LaDeana W Hillier; Steven Henikoff; Fabio Piano; Michael Snyder; Lincoln Stein; Jason D Lieb; Robert H Waterston
Journal:  Science       Date:  2010-12-22       Impact factor: 47.728

6.  The conserved immunoglobulin superfamily member SAX-3/Robo directs multiple aspects of axon guidance in C. elegans.

Authors:  J A Zallen; B A Yi; C I Bargmann
Journal:  Cell       Date:  1998-01-23       Impact factor: 41.582

7.  Genes that guide growth cones along the C. elegans ventral nerve cord.

Authors:  B Wightman; R Baran; G Garriga
Journal:  Development       Date:  1997-07       Impact factor: 6.868

8.  Oxygen levels affect axon guidance and neuronal migration in Caenorhabditis elegans.

Authors:  Roger Pocock; Oliver Hobert
Journal:  Nat Neurosci       Date:  2008-06-29       Impact factor: 24.884

9.  Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading.

Authors:  P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

10.  Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.

Authors:  Virginie Bros-Facer; David Krull; Adam Taylor; James R T Dick; Stewart A Bates; Matthew S Cleveland; Rabinder K Prinjha; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2014-03-25       Impact factor: 6.150

View more
  1 in total

Review 1.  Wound healing, cellular regeneration and plasticity: the elegans way.

Authors:  Laura Vibert; Anne Daulny; Sophie Jarriault
Journal:  Int J Dev Biol       Date:  2018       Impact factor: 2.203

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.